Avience Biomedicals Ltd.
•₹ 255.96.63%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.8%
- Company has a healthy return on capital (ROCE) of 27.5%
- Operating margins have improved to 26.6% from 12.0%
- Company comfortably covers its interest (10.8x coverage)
CONS
- Receivables are growing faster than sales - a possible quality concern
- Working capital days have increased from -135 to 84 days
- Equity base is being diluted - shares outstanding up 98.1%
- Total debt has risen sharply - up 77.8% year on year
- Free cash flow has been persistently negative
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | LENSKART | 639.30 | 169.67 | 111193.84 | 0.00 | 2284.30 | 3634.35 | 27141.80 | 1332.69 | 12.55 | 21.70 |
| 2. | POLYMED | 1771.60 | 56.99 | 17957.20 | 0.20 | 85.27 | -8.39 | 525.38 | 30.30 | 14.05 | 24.11 |
| 3. | MOLBIO | 1040.35 | 71.97 | 11988.99 | 0.00 | — | — | — | — | 19.79 | — |
| 4. | LAXMIDENTL | 195.65 | 34.85 | 1076.50 | 0.00 | 10.32 | 23.83 | 74.70 | 16.13 | 24.96 | 20.26 |
| 5. | 3BBLACKBIO | 1145.55 | 17.71 | 983.19 | 0.44 | 8.98 | -28.99 | 33.49 | 50.59 | 26.03 | 25.45 |
| 6. | AVIENCE | 234.90 | 14.72 | 128.84 | 0.00 | — | — | — | — | 34.16 | — |
| 7. | GKB | 63.95 | 9.94 | 32.23 | 0.00 | 1.85 | 387.99 | 33.04 | 2.26 | 8.82 | 7.97 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 10 | 11 | 16 | 29 | |
| 9 | 9 | 13 | 21 | |
| Operating Profit | 1 | 1 | 4 | 8 |
| OPM % | 12 | 13 | 22 | 29 |
| Other Income | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 | 1 |
| 1 | 1 | 3 | 7 | |
| Tax % | 26 | 26 | 26 | 26 |
| Net Profit | 1 | 1 | 2 | 5 |
| EPS | 5 | 3 | 6 | 13 |
| Dividend Payout % | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 2 | 6 | 13 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 2 | 6 | 13 |
Mar 2022
- 10
- 9
- Operating Profit
- 1
- OPM %
- 12
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 26
- Net Profit
- 1
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2023
- 11
- 9
- Operating Profit
- 1
- OPM %
- 13
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 26
- Net Profit
- 1
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2024
- 16
- 13
- Operating Profit
- 4
- OPM %
- 22
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 3
- Tax %
- 26
- Net Profit
- 2
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2025
- 29
- 21
- Operating Profit
- 8
- OPM %
- 29
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 7
- Tax %
- 26
- Net Profit
- 5
- EPS
- 13
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 42%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 93%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 33%
- Last Year:
- 39%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 2 | 3 | 3 | 4 |
| 1 | 1 | 3 | 16 | |
| 2 | 3 | 6 | 7 | |
| Trade Payables | 0 | 1 | 4 | 5 |
| 1 | 2 | 9 | 11 | |
| Total Liabilities | 6 | 10 | 26 | 44 |
| ASSETS | - | - | - | - |
| 1 | 3 | 7 | 9 | |
| Capital Work in Progress | 0 | 0 | 0 | 5 |
| 0 | 0 | 6 | 6 | |
| 1 | 4 | 8 | 8 | |
| 0 | 0 | 2 | 9 | |
| Cash & Bank | 0 | 0 | 0 | 5 |
| 3 | 4 | 3 | 3 | |
| Total Assets | 6 | 10 | 26 | 44 |
| Total Debt | 2 | 3 | 8 | 14 |
| Net Working Capital | 1 | 1 | -6 | 7 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 13.73 | 12.39 | 18.43 | 50.91 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 2 | 3 | 8 | 14 |
| Net Working Capital | 1 | 1 | -6 | 7 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 13.73 | 12.39 | 18.43 | 50.91 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2022
- Equity Capital
- 2
- 1
- 2
- Trade Payables
- 0
- 1
- Total Liabilities
- 6
- 1
- Capital Work in Progress
- 0
- 0
- 1
- 0
- Cash & Bank
- 0
- 3
- Total Assets
- 6
- Total Debt
- 2
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 13.73
- Face Value
- 10.00
- Total Debt
- 2
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 13.73
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 3
- 1
- 3
- Trade Payables
- 1
- 2
- Total Liabilities
- 10
- 3
- Capital Work in Progress
- 0
- 0
- 4
- 0
- Cash & Bank
- 0
- 4
- Total Assets
- 10
- Total Debt
- 3
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 12.39
- Face Value
- 10.00
- Total Debt
- 3
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 12.39
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 3
- 3
- 6
- Trade Payables
- 4
- 9
- Total Liabilities
- 26
- 7
- Capital Work in Progress
- 0
- 6
- 8
- 2
- Cash & Bank
- 0
- 3
- Total Assets
- 26
- Total Debt
- 8
- Net Working Capital
- -6
- Contingent Liabilities
- 0
- Book Value per Share
- 18.43
- Face Value
- 10.00
- Total Debt
- 8
- Net Working Capital
- -6
- Contingent Liabilities
- 0
- Book Value per Share
- 18.43
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 4
- 16
- 7
- Trade Payables
- 5
- 11
- Total Liabilities
- 44
- 9
- Capital Work in Progress
- 5
- 6
- 8
- 9
- Cash & Bank
- 5
- 3
- Total Assets
- 44
- Total Debt
- 14
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 50.91
- Face Value
- 10.00
- Total Debt
- 14
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 50.91
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -2 | 2 | 0 | 3 | |
| Cash from Investing | -1 | -2 | -4 | -8 |
| Cash from Financing | 3 | 0 | 4 | 9 |
| -0 | 0 | -0 | 4 | |
| Free Cash Flow | -2 | 0 | -5 | -4 |
| OCF / Net Profit | -2.73 | 2.24 | 0.12 | 0.62 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -2.73 | 2.24 | 0.12 | 0.62 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2022
- -2
- Cash from Investing
- -1
- Cash from Financing
- 3
- -0
- Free Cash Flow
- -2
- OCF / Net Profit
- -2.73
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.73
- Cumulative 5-Year FCF
- 0
Mar 2023
- 2
- Cash from Investing
- -2
- Cash from Financing
- 0
- 0
- Free Cash Flow
- 0
- OCF / Net Profit
- 2.24
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.24
- Cumulative 5-Year FCF
- 0
Mar 2024
- 0
- Cash from Investing
- -4
- Cash from Financing
- 4
- -0
- Free Cash Flow
- -5
- OCF / Net Profit
- 0.12
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.12
- Cumulative 5-Year FCF
- 0
Mar 2025
- 3
- Cash from Investing
- -8
- Cash from Financing
- 9
- 4
- Free Cash Flow
- -4
- OCF / Net Profit
- 0.62
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.62
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | 3.53 | 2.15 | 6.04 | 12.74 |
| Book Value (₹) | 13.73 | 12.39 | 18.43 | 50.91 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 3.07 | 2.78 | 7.37 | 14.54 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | 12.02% | 13.18% | 19.53% | 26.58% |
| Net Margin % | 7.08% | 6.48% | 12.20% | 17.77% |
| ROE % | 25.71% | 20.63% | 39.19% | 38.64% |
| ROCE % | 21.35% | 20.56% | 30.40% | 31.63% |
| 11.79% | 8.78% | 11.13% | 14.83% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 91 | 72 | 47 | 71 |
| Inventory Days | 53 | 84 | 128 | 101 |
| Payable Days | 11 | 35 | 94 | 98 |
| 133 | 121 | 82 | 75 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 0.89x | 0.65x | 1.28x | 0.67x |
| Interest Coverage (x) | 6.99x | 4.46x | 6.92x | 10.84x |
| 1.47x | 1.20x | 0.67x | 1.40x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | 7.62% | 48.85% | 77.73% |
| Operating Profit Growth % | 0.00% | 17.94% | 147.13% | 134.20% |
| Net Profit Growth % | 0.00% | -1.46% | 180.28% | 158.85% |
| 0.00% | 0.00% | 180.28% | 110.90% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 3.04x | 1.56x |
Mar 2022
- EPS (₹)
- 3.53
- Book Value (₹)
- 13.73
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.07
- Operating Margin %
- 12.02%
- Net Margin %
- 7.08%
- ROE %
- 25.71%
- ROCE %
- 21.35%
- 11.79%
- Debtor Days
- 91
- Inventory Days
- 53
- Payable Days
- 11
- 133
- Debt to Equity (x)
- 0.89x
- Interest Coverage (x)
- 6.99x
- 1.47x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 2.15
- Book Value (₹)
- 12.39
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.78
- Operating Margin %
- 13.18%
- Net Margin %
- 6.48%
- ROE %
- 20.63%
- ROCE %
- 20.56%
- 8.78%
- Debtor Days
- 72
- Inventory Days
- 84
- Payable Days
- 35
- 121
- Debt to Equity (x)
- 0.65x
- Interest Coverage (x)
- 4.46x
- 1.20x
- Revenue Growth %
- 7.62%
- Operating Profit Growth %
- 17.94%
- Net Profit Growth %
- -1.46%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 6.04
- Book Value (₹)
- 18.43
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.37
- Operating Margin %
- 19.53%
- Net Margin %
- 12.20%
- ROE %
- 39.19%
- ROCE %
- 30.40%
- 11.13%
- Debtor Days
- 47
- Inventory Days
- 128
- Payable Days
- 94
- 82
- Debt to Equity (x)
- 1.28x
- Interest Coverage (x)
- 6.92x
- 0.67x
- Revenue Growth %
- 48.85%
- Operating Profit Growth %
- 147.13%
- Net Profit Growth %
- 180.28%
- 180.28%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.04x
Mar 2025
- EPS (₹)
- 12.74
- Book Value (₹)
- 50.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.54
- Operating Margin %
- 26.58%
- Net Margin %
- 17.77%
- ROE %
- 38.64%
- ROCE %
- 31.63%
- 14.83%
- Debtor Days
- 71
- Inventory Days
- 101
- Payable Days
- 98
- 75
- Debt to Equity (x)
- 0.67x
- Interest Coverage (x)
- 10.84x
- 1.40x
- Revenue Growth %
- 77.73%
- Operating Profit Growth %
- 134.20%
- Net Profit Growth %
- 158.85%
- 110.90%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 1.56x
Documents
Announcements
Nothing filed yet.
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.